GlobeNewsWire
14 Nov 2025, 21:05 UTC · 51w ago
Verdict
Headline takes no side. We score VRCA +1.00 — strongly bullish.
+1.00strongly bullish
More positive than 98% of ticker scores this week
Scored by the NIS engine · methodology.
Search tags
Which stocks this story touches
Continue reading
5 related stories
More positive than 76% of relationship scores this week
[mutual] Verrica Pharmaceuticals and Torii Pharmaceutical are partners in the global Phase 3 clinical program of YCANTH in common warts.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Zacks Investment Research
30m ago
−5.3%
Price is moving against the score
$3.72 vs $3.93 close before publication (Nov 14) · not market-adjusted
VRCA chart →
